European Commission approves Pfizer’s RSV vaccine Abrysvo to help protect adults aged 18-59 against RSV lower respiratory tract disease

1 April 2025 - Abrysvo is the first and only RSV vaccine approved in the European Union for non-pregnant adults ...

Read more →

Bavarian Nordic receives US FDA approval of freeze dried smallpox and mpox vaccine

31 March 2025 - Bavarian Nordic today announced that the US FDA has approved the freeze dried formulation of Jynneos (smallpox ...

Read more →

Chlamydia vaccine candidate granted fast track designation by the US FDA

26 March 2025 - The US FDA has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of ...

Read more →

European Commission approves Merck’s Capvaxive (pneumococcal 21 valent conjugate vaccine) for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults

26 March 2025 - EC decision marks the fourth approval for Capvaxive for pneumococcal vaccination in adults ...

Read more →

Public Summary Documents (first time rejections and deferrals)– November 2024 PBAC meeting

21 March 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2024 PBAC ...

Read more →

mRESVIA RSV vaccine approved to protect patients aged 60 and over

28 February 2025 - A study found that around 4 months after vaccination, people who received the respiratory syncytial virus vaccine had ...

Read more →

Valneva receives EMA’s positive CHMP opinion for adolescent label extension for chikungunya vaccine Ixchiq

28 February 2025 - If granted, Ixchiq will become the first vaccine against the chikungunya virus available in the EU ...

Read more →

Bavarian Nordic receives US FDA approval of chikungunya vaccine for persons aged 12 and older

14 February 2025 - On track for commercial launch in the US in the first half of 2025. ...

Read more →

Penmenvy, GSK’s 5 in 1 meningococcal vaccine, approved by US FDA to help protect against MenABCWY

15 February 2025 - Broad serogroup coverage in one vaccine reduces injections to help improve vaccination rates and help protect ...

Read more →

European Commission approves CSL and Arcturus Therapeutics’ Kostaive, the first self-amplifying mRNA COVID-19 vaccine

14 February 2025 - Kostaive represents a significant advancement in vaccine technology, demonstrating superior immunogenicity and antibody persistence for up to ...

Read more →

Izchiq vaccine approved to protect adults against Chikungunya

4 February 2025 - The MHRA has today approved the vaccine chikungunya vaccine (live) (Ixchiq) to protect adults against chikungunya disease, ...

Read more →

Highlights from the 27-30 January 2025 CHMP meeting

31 January 2025 - Eight new medicines recommended for approval; one positive opinion for a medicine intended for use outside the ...

Read more →

GSK’s Shingrix new pre-filled syringe presentation accepted for review by EMA

27 January 2025 - If approved, the new presentation will offer a convenient administration option to healthcare professionals. ...

Read more →

Protection against RSV for mums and bubs with free vaccine available from 3 February

19 January 2025 - From 3 February 2025, Australian mums and their newborn babies will have free access to the best ...

Read more →

GSK’s Shingrix new pre-filled syringe presentation accepted for review by US FDA

10 January 2025 - An FDA decision on the application is expected by 20 June 2025. ...

Read more →